Lv51
1453 积分 2021-08-11 加入
Clinical Outcomes of Breast Cancer in Carriers ofBRCA1andBRCA2Mutations
54分钟前
已完结
Survival outcomes of patients with HER2/neu‐positive breast cancer with germline BRCA mutations
6小时前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
4天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
4天前
已完结
Pulsed electron avalanche knife (PEAK) for intraocular surgery
4天前
已关闭
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
7天前
已完结
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
8天前
已完结
Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer
14天前
已完结
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
14天前
已完结
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4
15天前
已完结
皖公网安备34019202002308
